These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12217618)

  • 1. Treatment of advanced stage patients with Parkinson's disease.
    Waters CH
    Parkinsonism Relat Disord; 2002 Oct; 9(1):15-21. PubMed ID: 12217618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing the late complications of Parkinson's disease.
    Waters CH
    Neurology; 1997 Jul; 49(1 Suppl 1):S49-57. PubMed ID: 9222274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition and management of neuropsychiatric complications in Parkinson's disease.
    Ferreri F; Agbokou C; Gauthier S
    CMAJ; 2006 Dec; 175(12):1545-52. PubMed ID: 17146092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.
    Deleu D; Hanssens Y; Northway MG
    Drugs Aging; 2004; 21(11):687-709. PubMed ID: 15323576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
    Jankovic J; Stacy M
    CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levodopa-related wearing-off in Parkinson's disease: identification and management.
    Pahwa R; Lyons KE
    Curr Med Res Opin; 2009 Apr; 25(4):841-9. PubMed ID: 19228103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease--levodopa complications.
    King DB
    Can J Neurol Sci; 1999 Aug; 26 Suppl 2():S13-20. PubMed ID: 10451755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographic and motor features associated with the occurrence of neuropsychiatric and sleep complications of Parkinson's disease.
    Munhoz RP; Teive HA; Eleftherohorinou H; Coin LJ; Lees AJ; Silveira-Moriyama L
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):883-7. PubMed ID: 23463867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical problems in non-fluctuating patients with Parkinson's disease: a community-based study.
    Larsen JP; Karlsen K; Tandberg E
    Mov Disord; 2000 Sep; 15(5):826-9. PubMed ID: 11009186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-motor symptoms in treated and untreated Chinese patients with early Parkinson's disease.
    Zhang H; Gu Z; An J; Wang C; Chan P
    Tohoku J Exp Med; 2014 Feb; 232(2):129-36. PubMed ID: 24573063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Parkinson's disease. Psychological disorders: striking a balance in order to optimise antiparkinsonian treatment.
    Prescrire Int; 2011 Oct; 20(120):242-5. PubMed ID: 21970092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep disorders in Parkinson's disease.
    Stocchi F; Barbato L; Nordera G; Berardelli A; Ruggieri S
    J Neurol; 1998 May; 245 Suppl 1():S15-8. PubMed ID: 9617717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuropsychiatric disorders in Parkinson's disease].
    Noé-Sebastián E; Irimia-Sieira P; Pomares-Arias E; Martínez-Vila E; Luquin-Piudo MR
    Rev Neurol; 2001 Apr 1-15; 32(7):676-81. PubMed ID: 11391498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safinamide as Add-On Therapy to Levodopa in Mid- to Late-Stage Parkinson's Disease Fluctuating Patients: Post hoc Analyses of Studies 016 and SETTLE.
    Cattaneo C; Sardina M; Bonizzoni E
    J Parkinsons Dis; 2016; 6(1):165-73. PubMed ID: 26889632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.
    Catalan MJ; Molina-Arjona JA; Mir P; Cubo E; Arbelo JM; Martinez-Martin P;
    J Neurol; 2018 Jun; 265(6):1279-1287. PubMed ID: 29557989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Freezing of gait in patients with advanced Parkinson's disease.
    Giladi N; Treves TA; Simon ES; Shabtai H; Orlov Y; Kandinov B; Paleacu D; Korczyn AD
    J Neural Transm (Vienna); 2001; 108(1):53-61. PubMed ID: 11261746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
    Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management for motor and non-motor complications in late Parkinson's disease.
    Chan DK; Cordato DJ; O'Rourke F
    Geriatrics; 2008 May; 63(5):22-7. PubMed ID: 18447408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced Parkinson disease.
    Antonini A; Nitu B
    J Neural Transm (Vienna); 2018 Aug; 125(8):1131-1135. PubMed ID: 30006821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study.
    Amboni M; Stocchi F; Abbruzzese G; Morgante L; Onofrj M; Ruggieri S; Tinazzi M; Zappia M; Attar M; Colombo D; Simoni L; Ori A; Barone P; Antonini A;
    Parkinsonism Relat Disord; 2015 Jun; 21(6):644-9. PubMed ID: 25899545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.